MetLife, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	19.07bn	17.36bn	17.34bn	18.57bn	18.44bn	17.82bn
Operating expenses	3.80bn	3.51bn	3.32bn	3.35bn	3.26bn	3.18bn
Pre-tax income	1.51bn	1.21bn	980m	1.35bn	1.99bn	1.20bn
Income tax	345m	308m	245m	404m	653m	249m
Net income	1.19bn	896m	729m	950m	1.34bn	946m
Earnings per share	1.75	1.23	1.04	1.29	1.82	1.28
Earnings per share, diluted	1.74	1.22	1.03	1.28	1.81	1.28

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	22.69bn	22.03bn	20.23bn	22.18bn	21.33bn	20.07bn	21.77bn	20.79bn
Short-term investments	4.95bn	3.60bn

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)